NATIONAL
HEALTHCARE 2023
Blokhin National Medical Research Centre of Oncology - tour ‘Achievements of Nuclear Medicine in Routine Oncological Practice’
- 30.11.2023
- 11:00–13:00
- 23, Kashirskoye Shosse, Moscow, enter opposite the fountain, hall of the 1st floor of the main building
Description of the tour ‘Achievements of Nuclear Medicine in Routine Oncological Practice’
Radioisotope Diagnostics Unit No. 2 (PET Unit) is the largest PET Unit in the CIS and one of the largest in Europe. The unit synthesizes radiopharmaceuticals that are unique to Russia and conducts preclinical and clinical trials together with other units of the oncology centre. The list of radiopharmaceuticals used in the PET department of the Blokhin Centre is one of the most extensive in the world and they meet almost all the needs of clinical oncology. In addition, the PET and Radionuclide Therapy Units are collaborating to introduce a theranostic approach to the treatment of a number of malignancies in which imaging is an integral part of patient care.
Route:
Visit to the Radiotherapy Unit (2nd floor, stairs)
Visit to Radioisotope Diagnostics Unit No. 2 in the hall of the 1st floor of building A
Visit to the Cyclotron and Radiochemical Unit (ground floor, stairs)
Visit to the treatment room and PET/CT control room (1st floor, stairs)
Artyom Pronin, Director, Department of Radionuclide Diagnostics and Therapy, Research Institute of Clinical and Experimental Radiology; Candidate of Medical Sciences; Associate Professor
Return to the 1st floor hall
All participants need lists in advance.
Foreign citizens need to submit their full name, place of work, and copies of their passports for approval in the security departments a week in advance.
All participants must have a passport with them.
Blokhin National Medical Research Centre of Oncology of the Ministry of Health of the Russian Federation is the largest oncology clinic in Russia and Europe and one of the largest oncology clinics in the world. Its arsenal includes the all the latest equipment and advanced techniques for diagnosing and treating cancer.
Our goal is to continuously improve the quality and accessibility of cancer care. To achieve this goal, we are working to improve the medical care system and introduce the latest technologies.
The centre includes five units:
• Trapeznikov Research Institute of Clinical Oncology with 900 beds
• Research Institute of Paediatric Oncology and Haematology with 299 beds
• Research Institute of Clinical and Experimental Radiology with 101 beds
• Research Institute of Carcinogenesis with 16 laboratories
• Research Institute for Experimental Diagnostics and Therapy of Tumours with 15 laboratories
The centre daily provides high-tech oncological care based on the best world standards, using numerous innovative and unique technologies to save patients.
There centre is home to eight departments of medical academies and universities.
The centre’s main activities include:
• Providing highly professional medical care to patients with malignant neoplasms and precancerous conditions;
• Conducting scientific research to study the biology of tumour cells and the mechanisms of carcinogenesis and tumour progression (molecular, virological, chemical, physical, genetic, cellular, and immunological aspects);
• Experimental and clinical development of new technologies for the surgical treatment of malignant tumours;
• Developing new diagnostic tools and methods, drug, radiation, and combination therapy, as well as active tumour prevention;
• Studying diagnostic, treatment, and prevention issues in paediatric oncology;
• Studying the epidemiology of malignant tumours and improving oncological statistics methods;
• Developing a national cancer screening programme together with preventive medicine specialists;
• Scheduling and holding telemedicine consultations in the following fields: oncology, radiotherapy, radiology, pathological anatomy, cytology, immunology, and paediatric oncology, among others;
• Handling the methodological management of Russia’s oncology service and drafting clinical recommendations, procedures, and standards for the provision of oncological care together with the professional community and the Ministry of Health of the Russian Federation;
• Incorporating new devices and technologies into the diagnostic and treatment process and to prevent malignant neoplasms;
• Training scientific and medical personnel through residency, postgraduate studies, and doctoral studies and in the continuing professional education system.
Ivan Stilidi, Chief Visiting Oncologist, Ministry of Health of the Russian Federation; Director, Blokhin National Medical Research Centre of Oncology of the Ministry of Health of the Russian Federation; Doctor of Medical Sciences; Professor; Academician, Russian Academy of Sciences
Radioisotope Diagnostics Unit No. 2 (PET Unit) is the largest PET Unit in the CIS and one of the largest in Europe. The unit synthesizes radiopharmaceuticals that are unique to Russia and conducts preclinical and clinical trials together with other units of the oncology centre. The list of radiopharmaceuticals used in the PET department of the Blokhin Centre is one of the most extensive in the world and they meet almost all the needs of clinical oncology. In addition, the PET and Radionuclide Therapy Units are collaborating to introduce a theranostic approach to the treatment of a number of malignancies in which imaging is an integral part of patient care.
Route:
Visit to the Radiotherapy Unit (2nd floor, stairs)
Visit to Radioisotope Diagnostics Unit No. 2 in the hall of the 1st floor of building A
Visit to the Cyclotron and Radiochemical Unit (ground floor, stairs)
Visit to the treatment room and PET/CT control room (1st floor, stairs)
Artyom Pronin, Director, Department of Radionuclide Diagnostics and Therapy, Research Institute of Clinical and Experimental Radiology; Candidate of Medical Sciences; Associate Professor
Return to the 1st floor hall
All participants need lists in advance.
Foreign citizens need to submit their full name, place of work, and copies of their passports for approval in the security departments a week in advance.
All participants must have a passport with them.
Blokhin National Medical Research Centre of Oncology of the Ministry of Health of the Russian Federation is the largest oncology clinic in Russia and Europe and one of the largest oncology clinics in the world. Its arsenal includes the all the latest equipment and advanced techniques for diagnosing and treating cancer.
Our goal is to continuously improve the quality and accessibility of cancer care. To achieve this goal, we are working to improve the medical care system and introduce the latest technologies.
The centre includes five units:
• Trapeznikov Research Institute of Clinical Oncology with 900 beds
• Research Institute of Paediatric Oncology and Haematology with 299 beds
• Research Institute of Clinical and Experimental Radiology with 101 beds
• Research Institute of Carcinogenesis with 16 laboratories
• Research Institute for Experimental Diagnostics and Therapy of Tumours with 15 laboratories
The centre daily provides high-tech oncological care based on the best world standards, using numerous innovative and unique technologies to save patients.
There centre is home to eight departments of medical academies and universities.
The centre’s main activities include:
• Providing highly professional medical care to patients with malignant neoplasms and precancerous conditions;
• Conducting scientific research to study the biology of tumour cells and the mechanisms of carcinogenesis and tumour progression (molecular, virological, chemical, physical, genetic, cellular, and immunological aspects);
• Experimental and clinical development of new technologies for the surgical treatment of malignant tumours;
• Developing new diagnostic tools and methods, drug, radiation, and combination therapy, as well as active tumour prevention;
• Studying diagnostic, treatment, and prevention issues in paediatric oncology;
• Studying the epidemiology of malignant tumours and improving oncological statistics methods;
• Developing a national cancer screening programme together with preventive medicine specialists;
• Scheduling and holding telemedicine consultations in the following fields: oncology, radiotherapy, radiology, pathological anatomy, cytology, immunology, and paediatric oncology, among others;
• Handling the methodological management of Russia’s oncology service and drafting clinical recommendations, procedures, and standards for the provision of oncological care together with the professional community and the Ministry of Health of the Russian Federation;
• Incorporating new devices and technologies into the diagnostic and treatment process and to prevent malignant neoplasms;
• Training scientific and medical personnel through residency, postgraduate studies, and doctoral studies and in the continuing professional education system.
Ivan Stilidi, Chief Visiting Oncologist, Ministry of Health of the Russian Federation; Director, Blokhin National Medical Research Centre of Oncology of the Ministry of Health of the Russian Federation; Doctor of Medical Sciences; Professor; Academician, Russian Academy of Sciences
